Status:

UNKNOWN

Prevention of Esophageal Variceal Rebleeding

Lead Sponsor:

National Science and Technology Council, Taiwan

Conditions:

Esophageal Variceal Rebleeding

Eligibility:

All Genders

18-80 years

Phase:

PHASE4

Brief Summary

BACKGROUND: Previous studies showed that the combination of endoscopic therapy with vasoconstrictor is better than either vasoconstrictor or endoscopic therapy alone in achieving the successful hemost...

Detailed Description

Methods of treatment: Group 1: Somatostatin 250μg slow bolus IV infusion followed by 250μg per hour (6mg/ 24 hours) or Terlipressin 2mg bolus was instituted on enrollment followed by 1mg per 6 hours ...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • The etiology of portal hypertension is cirrhosis.
  • Age ranges between 18-80 y/o.
  • Patients presenting with acute esophageal variceal bleeding proven by emergency endoscopy within 12 hours. (Acute esophageal variceal bleeding was defined as:
  • when blood was directly seen by endoscopy to issue from an esophageal varix (active bleeding) OR
  • when patients presented with red color signs on their esophageal varices with blood in esophagus or stomach and no other potential site of bleeding identified (inactive bleeding).
  • EVL is performed after confirmation of acute esophageal variceal bleeding. Enrollment time: Immediately after EVL is completed and variceal bleeding is arrested.
  • Exclusion criteria:
  • association with severe systemic illness, such as sepsis, COPD, uremia
  • association with gastric variceal bleeding
  • failure in the control of bleeding by emergency EVL
  • moribund patients, died within 12 hours of enrollment
  • Uncooperative
  • Ever received EIS, EVL within one month prior to index bleeding
  • Child-Pugh's scores \> 10

Exclusion

    Key Trial Info

    Start Date :

    December 1 2006

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 1 2009

    Estimated Enrollment :

    120 Patients enrolled

    Trial Details

    Trial ID

    NCT00863837

    Start Date

    December 1 2006

    End Date

    December 1 2009

    Last Update

    March 18 2009

    Active Locations (0)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 0 (0 locations)

    No Results Found

    We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

    Prevention of Esophageal Variceal Rebleeding | DecenTrialz